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North America’s only supervised injection facility, Insite, opened its doors in September of 2003 with a federal
exemption as a three-year scientific study. The results of the study, evaluated by an independent research team,
showed it to be successful in engaging the target group in healthcare, preventing overdose death and HIV
infections while increasing uptake and retention in detox and treatment. The research, published in peer-reviewed
medical and scientific journals, also showed that the program did not increase public disorder, crime or drug use.
Despite the substantial evidence showing the effectiveness of the program, the future of Insite came under threat
with the election of a conservative federal government in 2006. As a result, the PHS Community Services Society
(PHS), the non-profit organization that operates Insite, launched a legal case to protect the program. On 30
September 2011, Supreme Court of Canada ruled in favour of Insite and underscored the rights of people with
addictions to the security of their person under section 7 of the Charter of Rights and Freedoms (Charter of Rights).
The decision clears the ground for other jurisdictions in Canada, and perhaps North America, to implement
supervised injection and harm reduction where it is epidemiologically indicated. The legal case validates the
personhood of people with addictions while metaphorically unchaining them from the criminal justice system.“The philosophers have only interpreted the world in
various ways; the point, however, is to change it” [1].
After a long legal and cultural battle, North America’s
only supervised injection facility, Insite, is finally safe
from arbitrary political interference. This was a case
where personal experience, activism, advocacy, medicine
and science stood side-by-side to protect the rights of
even the most marginalized members of the community
to life-saving healthcare. The case began at the Supreme
Court of British Columbia and eventually made its way
to the Supreme Court of Canada (SCC). At the centre of
the case were the personal stories of people who relied
on supervised injection to stay alive together with testi-
mony from scientists, physicians, healthcare officials and
the operators of Insite. On 30 September 2011, Supreme
Court of Canada drew a legal line in the sand thatCorrespondence: dan@phs.ca
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reproduction in any medium, provided the orhighlights the rights of people with addictions to the se-
curity of their person under section 7 of the Charter of
Rights and Freedoms (Charter of Rights) [2]. The Char-
ter enshrines the values of Canadian culture regarding
the rights of individuals with respect to the provincial,
federal and territorial governments. The judges of Canada’s
highest court are appointed from a wide variety of political
backgrounds. The decision was unanimous and reinforced
the foundation of our understanding of addiction as a
healthcare matter in Canada.
As a caveat, I am not a distant academic examining
supervised injection from the point of view of a removed
observer. I am part of the senior management of the
non-profit organization that founded and operates Insite,
the PHS Community Services Society (PHS) and, as
such, I have been intricately involved in the develop-
ment, set-up, management and advocacy for Insite. I am
a participant observer and so this commentary is written
from the point of view of my personal experience.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lenges because it confronts our inner web of belief about
how to best approach addiction. Supervised injection
exists in a moral minefield at the very heart of our cul-
ture. By culture, I am speaking about what we believe to
be right and wrong, the implicit and explicit values that
are the building blocks of our understanding, practice
and societal approaches to people with addictions [3].
As such, it is my belief that this legal victory is about
something much more fundamental than the legal, med-
ical or scientific issues that arise from it. It points the
way towards a shift in our cultural orientation that
allows for addiction to be constructed as a social issue
best addressed, metaphorically, by the Chief of Medicine
rather than the Chief of Police (Figure 1).
This cultural change is best illustrated by a story from
only a decade ago when harm reduction was not widely
accepted or understood in Canada. Harm reduction
innovations involve attempting to reduce harms asso-
ciated with drugs, such as fatal overdoses, but to do so
without necessary eliminating the use of drugs (abstin-
ence). The Harm Reduction Journal provides the follow-
ing definition:
“We define 'harm reduction' as 'policies and programs
which aim to reduce the health, social, and economic
costs of legal and illegal psychoactive drug use
without necessarily reducing drug consumption'” [4].
In the year preceding the opening of Insite in 2003, I
was collaborating on a draft press release in response to
local opposition to harm reduction. The press release
simply stated that addiction is, primarily, a healthcare
matter. At that time, the notion of publicly stating that
addiction is a healthcare rather than criminal justice
issue was so controversial that I could not convince any-
one in the establishment to lend their name to the press
release. In the end, two community activists agreed to
sign their names to what was, at the time, a provocativeFigure 1 God distributing clean needles. Graphic by Flux Design.public statement. Now, ten years later; this has become
an established legal fact in Canada. Addiction is a
healthcare matter.
The PHS initiated the case at the Supreme Court of
British Columbia in 2008 to protect the program from
closure by a conservative federal government. We did
so at a time when there was no formal institutional
support for a struggle to protect Insite in the courts.
The only intervener was the British Columbia Civil
Liberties Association. Despite their role in co-managing
Insite, Vancouver Coastal Health (VCH) counseled our
organization not to turn to the courts to protect the
program and refused to provide any formal assistance
for the PHS to legally defend it. In the initial case,
neither Vancouver Health Authority (VCH), nor the
Attorney General of British Columbia sought inter-
vener status. Fortunately, the PHS was able to obtain
pro bono representation by three lawyers: Monique
Pongrecic-Speier, F. Andrew (Drew) Schroeder and Joseph
Arvay all of whom nobly took on the case when it felt like
Insite had been backed against the wall. A related and
important case, entered by the Vancouver Area Network
of Drug Users (Respondent/Appellant on cross appeal)
was heard jointly.
The PHS case focused on two overarching themes. The
first theme related to the division of powers between the
federal and provincial governments and essentially argued
that the operation of Insite falls under the jurisdiction of
the Province of British Columbia. The second argument
pertained to the Charter. The Charter is the first part of
the Constitution of Canada and contains a passage of par-
ticular relevance to Insite.2 This portion of the Charter,
section 7, is of central importance to Insite and states that:
“Everyone has the right to life, liberty and security of the
person and the right not to be deprived thereof except in
accordance with the principles of fundamental justice” [5]
(p. 4). The PHS argued the federal Health Minister’s with-
holding of an exemption from the Controlled Drugs and
Substances Act (CDSA) that was required at that time for
Insite’s operation was prejudicial and arbitrary. More so, it
jeopardized the life chances of people who need the facil-
ity to access life saving healthcare.
The case at the BC Supreme Court laid the ground-
work for the facts that would later form the foundation
for the landmark ruling at the Supreme Court of
Canada. Given the case’s importance, it is worth examin-
ing at a high level. There are, in my view, four key find-
ings of fact in this first case.
The first key fact pertains to the notion that addiction
is a healthcare matter. The Government of Canada con-
ceded this as an indisputable fact.
The presiding judge at the BC Supreme Court, Justice
Ian Pitfield, highlighted this absolutely critical cultural
admission in his Reasons for Judgment when he stated:
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of addiction as an illness allows for the devotion of
healthcare resources to addressing it.
The second fact that was established was that drugs, in
and of themselves, do not necessarily cause serious inter-
ruptions in health. Rather, it is the method, mechanism and
context within which drugs are ingested that brings about
danger:
“Controlled substances such as heroin or cocaine that
are introduced into the bloodstream by injection do
not cause Hepatitis C or HIV/AIDS. Rather, the use of
unsanitary equipment, techniques and procedures for
injection permits the transmission of those infections,
illnesses or diseases from one individual to another”
[6] (p. 33, para. 87).
This is the foundation of supervised injection as an
intervention. The point of intervention focuses on redu-
cing the harms associated with drug use without forcing
abstinence as a precondition for receiving healthcare.
The idea that drugs, as substances, are not automatic-
ally intrinsically evil or dangerous has been a culturally
controversial notion. There are, broadly speaking, two
competing overarching narratives about addiction [3].
The first narrative focuses, essentially, on drug use and
the drugs themselves as intrinsically dangerous. The sec-
ond does not centre on the drugs themselves, but instead
concentrates on the way drugs are administered (e.g. clean
versus unclean syringes) and the psycho-socio-cultural
context of their use (such as criminalization, poverty and
mental pain).
This distinction can be traced to the work of psychologist
Bruce K. Alexander who first discussed two orientations for
constructing addiction 30 years ago [7]. The first orienta-
tion essentially constructs addiction as follows: first a per-
son takes a drug, then, eventually, the drug takes the
person as a result of repeated exposure. Understanding ad-
diction in terms of an exposure to drug concentrates on the
eradication of drugs as the point of intervention. Following
on from this reasoning, it is the reduction in drug expo-
sures that will ultimately reduce or eliminate addiction. The
rival narrative about addiction, described in terms of coping
or adapting by Alexander and his colleagues constructs the
problem altogether differently. According to this alternative
explanation, people take drugs; drugs do not take people.
This perspective maintains that people misuse drugs due to
impoverished conditions and psychosocial pain that require
extraordinary coping strategies. In turning focus away from
the dangers of the drugs themselves to the ways in which
they are being used, the original court decision was aligned
with this latter orientation.
The third legal fact pertained to the notion that effect-
ive medical interventions are available to measurablyreduce the harms of addiction. The primary healthcare
intervention in Insite is the provision of sterile injection
equipment and the supervision of injection:
“The risk of morbidity and mortality associated
with addiction and injection is ameliorated by
injection in the presence of qualified health
professionals” [6] (p. 33, para. 87).
The finding of this fact, based on the scientific and
medical evidence before the court, established that a
supervised injection facility helps to prevent disease and
death. Contrary to its popular characterization as an iso-
lated program, Insite also offers detox and treatment on
site.
The final fact is perhaps the most culturally controver-
sial because it foregrounds the fact that effective health-
care interventions exist for addiction that do not
demand abstinence. Justice Pitfield understood that
while Insite is not traditional treatment, it is, nonethe-
less, important healthcare:
“While users do not use Insite directly to treat addiction,
they receive services and assistance at Insite which
reduce the risk of overdose that is a feature of their
illness, they avoid risk of being infected or of infecting
others by injection and they gain access to counselling
and consultation that may lead to abstinence and
rehabilitation. All of this is healthcare” [6] (p. 51, para.
136).
This recognition of this fact feeds into the cultural anxie-
ties about somehow enabling or encouraging addiction by
not outlawing it with vehemence. The ruling also addressed
this culturally notorious notion of overlooking addiction:
“Society cannot condone addiction, but in the face of
its presence it cannot fail to manage it, hopefully with
ultimate success reflected in the cure of the addicted
individual and abstinence” [6] (p. 54., para. 144).
The rival perspective, abstinence at all cost, would
presumably withhold supervised injection as a health-
care intervention even if it resulted in preventable fatal
overdoses. This was the very reason the PHS entered
the courts: we believe that harm reduction is a door-
way into treatment, detox and abstinence and that the
safeguarding of human life offered by supervised injec-
tion is sacrosanct. Without supervised injection,
people might perish from fatal overdoses before realiz-
ing the opportunity to one day pursue detox, treatment
and abstinence. Instead, all that would be left would be
a mortality statistic: a faint reminder that they ever
lived.
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heart of a particular cultural understanding of addiction:
1. Addiction is a healthcare matter.
2. Drugs to do not cause deadly HIV, HCV and fatal
overdoses: unclean needles and unsupervised
injection do.
3. Supervised injection is effective at preventing
morbidity and mortality. Harm reduction opens the
door to a range of healthcare (e.g. detox, treatment).
4. Abstinence, though laudable, is not compulsory for
effective healthcare interventions, with measurable
outcomes (e.g. such as saving lives by intervening in
otherwise fatal overdoses or preventing HIV) for
addiction. The idea of condoning or enabling
addiction with supervised injection takes second
place to keeping people alive.
The establishment of these four key facts, in my view,
laid the groundwork for both a legal and a cultural vic-
tory with respect to the notion of supervised injection.
As the case advanced, it gathered cultural momentum
as part of a growing acceptance of a particular under-
standing about addiction as described above. At the final
stage, 14 interveners had joined the proceedings includ-
ing: the Vancouver Coastal Health Authority, Canadian
Nurses Association, British Columbia Nurses’ Union,
Registered Nurses’ Association of Ontario, Association
of Registered Nurses of British Columbia, Canadian
Medical Association, Canadian Civil Liberties Association,
Canadian HIV/AIDS Legal Network, International Harm
Reduction Association, CACTUS Montreal (a non-profit
organization dedicated to providing non-judgmental as-
sistance and risk reduction for at risk individuals including
those use illicit drugs, street involved youth, sex trade
workers as well as transvestite and transsexual persons),
Canadian Public Health Association, British Columbia
Civil Liberties Association, Attorney General of
Quebec and Dr. Peter AIDS Foundation. The Attor-
ney General of British Columbia was a respondent
with regard to the doctrine of inter-jurisdictional im-
munity that was won at the Appeal Court level and
argued for localized control over Insite as a provincial
initiative.
Sadly, there has always been a psychosocial
phenomenon that is culturally expunged or relegated to
the shadows due to the moral anxieties that it creates in
the wider community. This has been true in the case in
the present and past with issues or experiences that
make people uncomfortable such as death, sexuality,
mental illness or addiction which are sequestered in so-
cial life and institutional settings [8]. This process of
sequestering, or hiding away of the social phenomena
that alarm or anger us, also takes its shape in the formof cultural erasures and silences, things that are unsaid
which can, in actuality, be more influential than what is
said [9]. Addiction is just such a phenomenon; people
with addictions have been sequestered, silenced and
erased from positive social life. Their personhood has
been so dramatically undermined that their identities are
sometimes socially spoiled [10] leaving them metaphor-
ically chained. Throughout the education campaign to
save Insite, we attempted to combat this identity erosion
by highlighting the personhood of people living with
addictions by echoing the idea that everyone living with
addictions was someone’s son or daughter (Figure 2).
The field of mental health provides an interesting ana-
logy with respect to the process of liberation of people
with pain from societal shackles of stigma and incarcer-
ation. Psychiatry’s approach to people with mental ill-
nesses transitioned towards humanistic treatment in the
1780’s under the leadership of more humanistic psychia-
trists and reforms in the mental health field. Physician
Vincenzo Chiarugi (1759–1820) led a movement espous-
ing the humane treatment of the mentally ill which took
its first applied step, in practice, in 1788 with the open-
ing of Hospital Bonifacio in Florence, Italy where he
served as the physician director [11]. Chiarugi’s ap-
proach was in keeping with the goals of Grand Duke
Pietro Leopold of Tuscany, a socially conscious aristo-
crat who ordered the establishment of Bonifazio, and
was predicated on respectful and humane treatment
[12]. He is a significant figure in the history of humanis-
tic medicine and one of the fathers of compassionate
psychiatry. Chiarugi is thought to be the first figure to
forbid the use of chains to restrain the mentally ill (a
policy which he established during his role as physician
director of Santa Doretea hospital before 1793) [12].
Similarly, Jean-Baptiste Pussin (1746–1811) and
Madame Marguerite Pussin (1754-?) helped to infuse com-
passion into the practice of mental health [12,13]. After
having been a patient at Bicêtre hospital in the suburbs of
Paris, Jean-Baptiste Pussin went on to become the director
of a psychiatric ward from 1785 to 1802 during which time
he implemented a series of compassionate improvements
in the treatment of mentally ill [14]. Pussin outlawed the
employment of chains to imprison the mentally ill in 1797
while serving as the governor of Bicêtre [12]. Pussin is an
important forerunner in the history of humanistic mental
health services.
In popular culture, physician Phillippe Pinel is widely
thought of as being the first individual to liberate the
mentally ill from chains. The renowned painting Mad-
women at the Salpêtrière, painted by Tony-Robert
Fleury, has helped to immortalize this legend. The paint-
ing shows Pussin removing the chains of psychiatric
patients while Pinel looks on and symbolizes a transition
towards more humanistic approaches to the mentally ill
Figure 2 This should not be an injection site. Graphic by PHS Community Services Society.
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trance to the Library Charcot in the Salpêtrière hospital
[14].
In fact, it was Pussin who inspired Pinel to ban the use
of chains for detaining people living with mental ill-
nesses [12,15]. After having worked at Bicêtre between
1793 and 1795, Philippe Pinel was so inspired by the
work of Pussin that he credited him with the emancipa-
tion of the mentally ill and the first actual application of
humanistic psychiatric treatment. When Pinel moved toSalpêtrière, the largest hospital in Paris, he established a
post for Pussin who took up the position there from
1801 until his death in 1811.14 At Salpêtrière in Paris,
Pussin and Pinel worked together to apply humanistic
approaches to psychiatric treatment.
There is some humanistic truth at the heart of legend-
ary characterization of Pinel as the person that liberated
the mentally ill from their chains. He did, in fact,
showed significant leadership by moving away from
abandonment and brutal imprisonment to a therapeutic
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[12]. Similarly, the Insite legal case helps to make a simi-
lar transition from the cruelty of criminalization in ad-
diction to a healthcare model where people with
addiction have fundamental rights to life saving
healthcare.
The mental health field transitioned from a model
based on incarceration and neglect of the mentally ill to
an approach based on compassion, science and medical
treatment in the 18th century. In the addiction field, this
transition has taken another two centuries (21st century).
The metaphor of chaining of the addicted goes beyond the
symbolic. In 2009, the US incarcerated more than 400,000
individuals for non-violent drug offenses (a greater number
than those incarcerated for all offenses in the 27 nations of
the European Union combined [16].
The incarceration of the addicted has been so dra-
matic that, when seen through the lens of epidemi-
ology, it can be considered as a catastrophic event that
has resulted in tremendous suffering and death. The
epidemiological tool of years of life lost (YLL) is useful
for examining the impact of a criminal justice approach
to addiction. Drucker defines years of life lost as “the
number of years between the victim’s age at death and
the age that his or her usual life expectancy would pre-
dict. Thus, for the average American with a life expect-
ancy of 75years, a child’s death at age ten implies a loss
of sixty-five potential years of life [16] (p.69). Building
on this logic, Drucker notes that 1,513 people died
representing an estimated 47,000 YLL in the Titanic
disaster, 2,819 deaths representing an estimated
104,303 YLL died in the World Trade Centre tragedy
and reasons that over the past 35years (since the intro-
duction of the Rockefeller drug laws in New York),
more than 7 million people have been incarcerated.
This translates into an estimated 14 million YLL repre-
senting 350,000 deaths in a group of the same age [16].
In 2009 alone, more than 400,000 individuals were
incarcerated for non-violent drug offenses in the United
States. This represents a greater number than all those
incarcerated for all offenses in the 27 nations of the
European Union combined [16]. The Insite victory is
emblematic of a different cultural understanding of ad-
diction that is supplanting a traditional one. This newer
approach assumes people living with addictions are in
need of healthcare rather than punishment through the
criminal justice system.
By focusing on the federal Health Minister’s refusal to
provide an exemption for Insite under the existing regu-
latory framework, the SCC did not have to make any
alterations to existing provincial and federal jurisdictions
over the program. Canada’s federal government
attempted to argue that the federal minister of health
had, technically, never “not given” a permit for Vancouver’ssupervised injection site and therefore never formally jeo-
pardized its operation. However, the court ruled that it was
self-evident that the federal Health Minister had every
intention to close Insite:
“The Minister of Health must be regarded as having
made a decision whether to grant an exemption, since
he considered the application before him and decided
not to grant it. The Minister’s decision, but for the trial
judge’s interim order, would have prevented injection
drug users from accessing the health services offered by
Insite, threatening their health and indeed their lives
[emphasis added] [2] (p. 9).
The SCC concluded that the Minister’s intention to
shut Insite would have threatened the lives of the people
who rely on the program. It also noted the program
would not have remained open had it not been for pro-
tection provided by the Supreme Court of BC (Figure 3).
National public policy with respect to supervised injec-
tion in Canada began with the establishment of a loca-
lized response to a healthcare emergency. Supervised
injection, in this case, began from the ground up rather
from a top down policy. The goals of Insite originated
out of local need, inspired by the idea that people with
addictions deserved something better than death from
overdose. The goals and outcome measures were simple.
The program aimed to provide a doorway to life, sup-
ported housing, physicians, healthcare services and sup-
ports. The intent of the program was to provide its
interventions (e.g. clean syringes, supervised injection)
in an accessible way without barriers (such as abstinence
or onerous intake procedures).
One thing that is clearly demonstrated by the case of
Insite is that science is not enough, on its own, to
change public policy especially in stigmatized areas like
addiction. The simple existence of a scientific evidence
base does not automatically lead to changes in policies
or practice. Policy makers and elected officials need to
pay attention to the evidence base. In some disappoint-
ing instances, as the case of Insite has shown, policy
makers need to be forced to pay attention to the estab-
lished facts. Conversely, scientists need to take an active
role in affecting public policy when the evidence indi-
cates the need for change [17]. The SIF, for instance, had
more than three-dozen peer-reviewed papers associated
with its evaluation [18–47]. Despite the fact that much
of the evaluation was paid for by the Government of
Canada, they chose to ignore the scientific findings. The
evidence base generated by Canada’s supervised injection
trial should have earned it a medical exemption (the
next stage of operational permit after the scientific
authorization originally granted to Insite) but it was not
provided. Uncompromising advocacy, including public
protest and legal challenge, was required to obtain the
permit.
Figure 3 Safe injection site demonstration. Graphic by PHS Community Services Society.
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are not the same [48]. While science in healthcare is
portrayed as "objective", applied research is seen as
rooted in the context of the community needs. From my
perspective, science in healthcare needs to move more
towards clinical application. Yes, it needs to be sound
and rigorous, but its main purpose should be to serve
the patients, families and the community. Scientific
evaluation of the Insite may have been a necessary con-
dition but it was certainly not a sufficient condition to
bring about a permanent change in public policy or a
sustainable supervised injection facility.Sometimes scientists and bureaucrats spend too much
time worrying about protecting objectivity at the ex-
pense of advocacy. Yet, there are, time and time again,
instances where advocacy needs to be undertaken and
undertaken vigorously. The supervised injection facility
was one of those times. It demanded public advocacy.
Despite the victory, on the day of court announcement, I
felt relief more than elation. I couldn’t help but wonder
what would have happened to Insite if things had been
different? If we had lost the court case, would the vari-
ous stakeholders have chosen the ethically sound course
of action by continuing to operate in spite of an unjust
Figure 4 Safe injection sites now. Graphic by Flux Design.
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have been a strong ethical case for breaking the law and
keeping Insite open. There was no scientific uncertainty
about the effectiveness of Insite at engaging a hard to
reach population in healthcare and saving lives. The only
equipoise was political. Had we lost, would we have been
forced to live through a medical, legal and ethical disas-
ter while people died of preventable overdoses because it
was against the law? These are dark questions that
haunted Insite right up until the very moment that the
final decision was rendered. Thankfully, we never had to
publically confront what might have been had we lost.
In my view, there are three important cultural ramifi-
cations of this case. Firstly, this legal decision says a lot
about what it is to be a person, to have personhood, in
Canada. Personhood symbolizes our connection to the
wider human family [49]. What it is to be a person exists
in the borderland of human relations where personal
agency and meaning are psychosocially constructed as
part of an inner and outer conversation. Socially deva-
lued features of our selves such as addiction reduce our
opportunities to be on the threshold of a successful life
[10]. The personhood of people with addiction is often
undermined or threatened by policies, programs and im-
plicit or explicit exclusion (e.g. drug courts and thera-
peutic communities are typically founded on the principle
that addicts must abdicate a portion of their self-deter-
mination). The personhood of people with addictions in
Canada has been emphasized and their constitutional
rights feature prominently in this legal ruling.
The second consequence of this case is that other jur-
isdictions may, and should, establish supervised injection
if the epidemiological variables demand it. On this point,
I disagree with the overemphasis on obtaining consensus
from an overly broad collection of stakeholders (e.g. the
municipal government, the local police) who are typic-
ally consulted in order to obtain their blessing so that
lives can be saved by supervised injection. A letter of
support from the Chief of Police or Mayor of a city
would not be required to establish a cancer treatment
program. Correspondingly, one shouldn’t be required in
the case of harm reduction programs. If the evidence
base is there to support an intervention, then we should
move past consensus building when it comes to life saving
healthcare. The SCC has ruled that the morality of an ac-
tivity, such as drug addiction, isn’t enough to ignore some-
one’s rights to security of their person under section 7 of
Canada’s Charter of Rights and Freedoms (the Charter):
“Additionally, the morality of the activity the law
regulates is irrelevant at the initial stage of
determining whether the law engages a s. 7 right.
Finally, the issue of illegal drug use and addiction is a
complex one which attracts a variety of social,political, scientific and moral reactions. While it is for
the relevant governments to make criminal and health
policy, when a policy is translated into law or state
action, those laws and actions are subject to scrutiny
under the Charter” [2] (p.9).
The suitability of supervised injection shouldn’t be
debated any longer as though it were on par with a dis-
cussion on a sports show about which sports team will
Figure 5 Church Marquee in Vancouver’s Downtown Eastside. Photograph by Dan Small.
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and whether it is required in a jurisdiction needs to be
determined by evidence and not arbitrary opinions or
fickle political stances in search of votes. If science and
medicine have established the best course of action, then
we shouldn’t turn to opinion polls to determine the best
healthcare (Figure 4).
Finally, it is my opinion that this ruling provides fur-
ther affirmation that many healthcare providers know:
harm reduction needs to be an explicit part of the
standard of care now. Every single health authority and
region in Canada should have a proactive policy detail-
ing best practices in harm reduction when it is epide-
miologically indicated. It is simply not acceptable to
pretend harm reduction doesn’t exist or to let moral
opposition rather than evidence based analysis guide
decisions in this area.
Any jurisdiction that doesn’t a positive policy on harm
reduction is misguided. An example is provided by the
City of Abbotsford in British Columbia. In June 2005,
Abbotsford amended their zoning (bylaw no. 1378–2004)
in order to overtly exclude harm reduction:
“Prohibited uses would include safe injection sites,
needle exchanges, mobile dispensing vans, methadonetreatment facilities and other types or similar uses.”
The experience of Insite should be an important lesson
for jurisdictions that ignore, or in the case of Abbots-
ford, outlaw, harm reduction as part of healthcare. They
do so at their own peril legally, medically and ethically
(Figure 5).
This commentary is not meant to be a distant scien-
tific paper but, instead, an experience-based and socially
positioned interpretation of events that I have lived. As
one of the creators of Insite, I had always imagined that
establishing an injection site would be the most difficult
task to accomplish. In fact, it seems to me that the pro-
tection of it, once established, has been an even larger
challenge. The struggle to protect Insite has distracted
us from many other important prevention, treatment,
enforcement and harm reduction initiatives that need to
be established to comprehensively address addiction.
The fact that the program has survived is itself an indi-
cator of social change and I believe that this ruling sig-
nals that we have reached an important cultural
milestone. We’ve gone so much further than hoping that
addiction will one day be understood as a healthcare
matter. The very fact that Insite can exist, with the per-
manence of a Supreme Court decision, supports harm
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tainability it deserves. With this ruling, we’ve moved be-
yond hopefulness to a point in our history where people
with addictions have been unchained. Canada’s highest
court has spoken. It’s the law.
“If you have built castles in the air, your work need
not be lost; that is where they should be. Now put the
foundations under them [50] (p.255).
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